• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内源性逆转录病毒序列作为一类新型的肿瘤特异性抗原:以 HERV-H env 编码强 CTL 表位为例。

Endogenous retrovirus sequences as a novel class of tumor-specific antigens: an example of HERV-H env encoding strong CTL epitopes.

机构信息

Department of General, Thoracic, Vascular and Transplantation Surgery, Section Molecular Oncology and Immunotherapy, University of Rostock, Germany.

出版信息

Cancer Immunol Immunother. 2012 Jul;61(7):1093-100. doi: 10.1007/s00262-011-1183-3. Epub 2011 Dec 21.

DOI:10.1007/s00262-011-1183-3
PMID:22187063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11029769/
Abstract

Our genome consists to about 8% of human endogenous retroviral (HERV) sequences. These HERVs have been discussed to be linked to human diseases for decades. Recently, a detailed analysis of a HERV-H sequence located on chromosome Xp22.3 revealed a strong expression in a subset of gastrointestinal cancers whereas expression in normal tissues and in other cancer entities was low. In the present study, we used the reverse immunology approach to test the immunological potential of this HERV-H ORF on Xp22.3. A total of ten peptides displaying HLA-A2.1-binding motifs were selected from the predicted env protein sequence. Stimulation of peripheral T cells with retroviral peptides (RVPs) presented by autologous antigen-presenting cells clearly resulted in sustained proliferation of predominantly CD8(+) T cells. High numbers of IFN-γ-secreting T cells were detectable after several weekly stimulations with RVP mixes. Reactivity observed in RVP-Mix-stimulated cultures was attributable to RVP03, RVP09 and to a lower extend to RVP08, suggesting those to be highly immunogenic epitopes. Besides killing of RVP-loaded target cells, up to 40% specific lysis of colorectal carcinoma cell lines endogenously expressing this HERV-H Xp22.3 ORF was achieved. These data demonstrate that human T cells can be sensitized toward HERV peptides and moreover posses a high lytic potential toward HERV-H expressing CRC cells. Additionally, these data hint toward endogenous ENV protein expression followed by proteasomal degradation and presentation in the context of HLA molecules. Finally, our data strengthen the view that HERV-encoded sequences should be considered as a new class of tumor-specific antigens.

摘要

我们的基因组约有 8%是人类内源性逆转录病毒(HERV)序列。这些 HERV 已经被讨论了几十年,与人类疾病有关。最近,对位于 Xp22.3 染色体上的 HERV-H 序列的详细分析表明,它在胃肠道癌症的一个亚群中强烈表达,而在正常组织和其他癌症实体中的表达较低。在本研究中,我们使用反向免疫学方法来测试 Xp22.3 上的这个 HERV-H ORF 的免疫潜力。从预测的 env 蛋白序列中选择了十个显示 HLA-A2.1 结合基序的肽。用自体抗原呈递细胞呈递的逆转录病毒肽(RVPs)刺激外周 T 细胞,明显导致主要是 CD8+T 细胞的持续增殖。在用 RVP 混合物进行几次每周刺激后,可检测到大量 IFN-γ 分泌的 T 细胞。在 RVP-Mix 刺激的培养物中观察到的反应归因于 RVP03、RVP09,以及较低程度的 RVP08,表明它们是高度免疫原性的表位。除了杀伤负载 RVP 的靶细胞外,还可以实现对天然表达该 HERV-H Xp22.3 ORF 的结直肠癌细胞系高达 40%的特异性溶解。这些数据表明,人类 T 细胞可以对 HERV 肽产生敏感性,并且对表达 HERV-H 的 CRC 细胞具有高裂解潜力。此外,这些数据表明存在内源性 ENV 蛋白表达,随后进行蛋白酶体降解,并在 HLA 分子的背景下呈递。最后,我们的数据强化了这样一种观点,即 HERV 编码的序列应被视为一类新的肿瘤特异性抗原。

相似文献

1
Endogenous retrovirus sequences as a novel class of tumor-specific antigens: an example of HERV-H env encoding strong CTL epitopes.内源性逆转录病毒序列作为一类新型的肿瘤特异性抗原:以 HERV-H env 编码强 CTL 表位为例。
Cancer Immunol Immunother. 2012 Jul;61(7):1093-100. doi: 10.1007/s00262-011-1183-3. Epub 2011 Dec 21.
2
Human leukemia antigen-A*0201-restricted epitopes of human endogenous retrovirus W family envelope (HERV-W env) induce strong cytotoxic T lymphocyte responses.人类内源性逆转录病毒W家族包膜(HERV-W env)的人类白血病抗原-A*0201限制性表位可诱导强烈的细胞毒性T淋巴细胞反应。
Virol Sin. 2017 Aug;32(4):280-289. doi: 10.1007/s12250-017-3984-9. Epub 2017 Aug 22.
3
A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes.一种编码被细胞毒性T淋巴细胞识别的黑色素瘤抗原的人类内源性逆转录病毒序列。
Cancer Res. 2002 Oct 1;62(19):5510-6.
4
Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells.人内源性逆转录病毒 K 特异性 T 细胞对自体卵巢癌细胞的细胞毒性。
Clin Cancer Res. 2015 Jan 15;21(2):471-83. doi: 10.1158/1078-0432.CCR-14-0388. Epub 2014 Nov 4.
5
Chromosomal distribution and coding capacity of the human endogenous retrovirus HERV-W family.人类内源性逆转录病毒HERV-W家族的染色体分布及编码能力
AIDS Res Hum Retroviruses. 2000 May 20;16(8):731-40. doi: 10.1089/088922200308738.
6
Full-length HERV-H elements with env SU open reading frames in the human genome.人类基因组中带有env SU开放阅读框的全长HERV-H元件。
AIDS Res Hum Retroviruses. 2002 Jun 10;18(9):671-6. doi: 10.1089/088922202760019383.
7
Expression profiles of human endogenous retrovirus (HERV)-K and HERV-R Env proteins in various cancers.人类内源性逆转录病毒(HERV)-K 和 HERV-R Env 蛋白在各种癌症中的表达谱。
BMB Rep. 2021 Jul;54(7):368-373. doi: 10.5483/BMBRep.2021.54.7.246.
8
Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer.多种人类内源性逆转录病毒表面包膜蛋白在卵巢癌中的表达
Int J Cancer. 2007 Jan 1;120(1):81-90. doi: 10.1002/ijc.22256.
9
HLA DR2b-binding peptides from human endogenous retrovirus envelope, Epstein-Barr virus and brain proteins in the context of molecular mimicry in multiple sclerosis.人类内源性逆转录病毒包膜、Epstein-Barr 病毒和脑蛋白中的 HLA DR2b 结合肽在多发性硬化症中的分子模拟。
Immunol Lett. 2020 Jan;217:15-24. doi: 10.1016/j.imlet.2019.10.017. Epub 2019 Nov 3.
10
Human endogenous retroviruses env gene expression and long terminal repeat methylation in colorectal cancer patients.人类内源性逆转录病毒 env 基因表达和长末端重复甲基化在结直肠癌患者中的研究。
Med Microbiol Immunol. 2020 Apr;209(2):189-199. doi: 10.1007/s00430-020-00662-6. Epub 2020 Feb 10.

引用本文的文献

1
A plan or pandemonium? The conundrum of retrotransposon activation in cancer.计划还是混乱?癌症中逆转录转座子激活的难题。
Mob DNA. 2025 Aug 9;16(1):31. doi: 10.1186/s13100-025-00368-7.
2
Exploring transposable elements: new horizons in cancer diagnostics and therapeutics.探索转座子:癌症诊断与治疗的新视野。
Mob DNA. 2025 Jul 12;16(1):28. doi: 10.1186/s13100-025-00366-9.
3
Tumor antigens preferentially derive from unmutated genomic sequences in melanoma and non-small cell lung cancer.肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未发生突变的基因组序列。
Nat Cancer. 2025 May 22. doi: 10.1038/s43018-025-00979-2.
4
Combination Therapy Approaches to Enhance the Efficacy of ERV-Targeting Vaccines in Cancer.增强癌症中靶向ERV疫苗疗效的联合治疗方法
Cancer Immunol Res. 2025 Jun 4;13(6):792-803. doi: 10.1158/2326-6066.CIR-24-1192.
5
Deciphering human endogenous retrovirus expression in colorectal cancers: exploratory analysis regarding prognostic value in liver metastases.解读人类内源性逆转录病毒在结直肠癌中的表达:关于肝转移预后价值的探索性分析。
EBioMedicine. 2025 Jun;116:105727. doi: 10.1016/j.ebiom.2025.105727. Epub 2025 May 16.
6
Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control.一种靶向内源性逆转录病毒包膜蛋白ERVMER34-1的治疗性癌症疫苗与免疫肿瘤药物联合使用,有助于新表位特异性T细胞的扩增并促进肿瘤控制。
J Immunother Cancer. 2025 May 13;13(5):e011378. doi: 10.1136/jitc-2024-011378.
7
HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy.缺氧诱导因子调节多种转译内源性逆转录病毒:对癌症免疫治疗的启示。
Cell. 2025 Apr 3;188(7):1807-1827.e34. doi: 10.1016/j.cell.2025.01.046. Epub 2025 Feb 28.
8
Epigenetic therapy potentiates transposable element transcription to create tumor-enriched antigens in glioblastoma cells.表观遗传学疗法增强转座元件转录,在胶质母细胞瘤细胞中产生富含肿瘤的抗原。
Nat Genet. 2024 Sep;56(9):1903-1913. doi: 10.1038/s41588-024-01880-x. Epub 2024 Sep 2.
9
Dysregulation of Transposon Transcription Profiles in Cancer Cells Resembles That of Embryonic Stem Cells.癌细胞中转座子转录谱的失调类似于胚胎干细胞的转录谱失调。
Curr Issues Mol Biol. 2024 Aug 5;46(8):8576-8599. doi: 10.3390/cimb46080505.
10
Autophagy degrades immunogenic endogenous retroelements induced by 5-azacytidine in acute myeloid leukemia.自噬降解 5-氮杂胞苷诱导的急性髓系白血病中的免疫原性内源性逆转录元件。
Leukemia. 2024 May;38(5):1019-1031. doi: 10.1038/s41375-024-02250-6. Epub 2024 Apr 16.

本文引用的文献

1
Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.强烈的人类内源性逆转录病毒特异性 T 细胞应答与慢性感染中 HIV-1 的控制有关。
J Virol. 2011 Jul;85(14):6977-85. doi: 10.1128/JVI.00179-11. Epub 2011 Apr 27.
2
Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer.内源性逆转录病毒介导的人类癌症中基因组不稳定性的潜在机制。
Semin Cancer Biol. 2010 Aug;20(4):246-53. doi: 10.1016/j.semcancer.2010.05.005. Epub 2010 May 26.
3
HERVs in neuropathogenesis.人类内源性逆转录病毒在神经发病机制中的作用。
J Neuroimmune Pharmacol. 2010 Sep;5(3):326-35. doi: 10.1007/s11481-010-9214-y. Epub 2010 Apr 27.
4
Identification of an MSI-H tumor-specific cytotoxic T cell epitope generated by the (-1) frame of U79260(FTO).鉴定由U79260(FTO)的(-1)读码框产生的微卫星高度不稳定(MSI-H)肿瘤特异性细胞毒性T细胞表位。
J Biomed Biotechnol. 2010;2010:841451. doi: 10.1155/2010/841451. Epub 2010 Mar 18.
5
Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control.定制的人类内源性逆转录病毒专用微阵列鉴定了在睾丸癌中经甲基化控制重新激活的自身诱导的 HERV-W 家族元件。
Nucleic Acids Res. 2010 Apr;38(7):2229-46. doi: 10.1093/nar/gkp1214. Epub 2010 Jan 6.
6
Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelements.肿瘤中表观遗传沉默的丧失优先影响灵长类特异性逆转录元件。
Gene. 2009 Dec 15;448(2):151-67. doi: 10.1016/j.gene.2009.08.006. Epub 2009 Aug 21.
7
Structural and quantitative expression analyses of HERV gene family in human tissues.人类组织中内源性逆转录病毒基因家族的结构和定量表达分析。
Mol Cells. 2009 Aug 31;28(2):99-103. doi: 10.1007/s10059-009-0107-y. Epub 2009 Jul 30.
8
Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classification.在分子分类中无CpG岛甲基化表型的染色体和微卫星稳定型结直肠癌
Int J Oncol. 2009 Aug;35(2):321-7.
9
Evolution of human endogenous retroviral sequences: a conceptual account.人类内源性逆转录病毒序列的演变:概念阐述。
Cell Mol Life Sci. 2008 Nov;65(21):3348-65. doi: 10.1007/s00018-008-8495-2.
10
Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients.人类内源性逆转录病毒K在乳腺癌患者中引发抗原特异性免疫反应。
Cancer Res. 2008 Jul 15;68(14):5869-77. doi: 10.1158/0008-5472.CAN-07-6838.